Muscle Growth Following a Resistance Training Program in Men and Women Consuming Protein Supplements

February 25, 2020 updated by: Heidi Lynch, Point Loma Nazarene University

Muscle Growth and Development Following a 12-week Resistance Training Program in Men and Women Consuming Soy and Whey Protein Supplements

Soy and whey protein have different concentrations of leucine, an amino acid known to be a particularly potent simulator of muscle protein synthesis. The purpose of this study is to determine whether matching soy and whey protein supplements for leucine content instead of by total protein content would contribute to differences in strength increases and muscle growth in response to 12 wk of resistance training.

Study Overview

Study Type

Interventional

Enrollment (Actual)

61

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Phoenix, Arizona, United States, 85004
        • Arizona State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • non-smoking
  • body mass index (BMI) 18.5-24.9
  • recreationally active

Exclusion Criteria:

  • participated in structured weight training during the previous 12 month
  • vegetarian or vegan
  • presence of chronic disease
  • pregnant, postpartum up to six months, lactating, or intention to become pregnant
  • allergy to whey or soy
  • changes in body weight more than 10 pounds in the past three months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Soy protein group
26 g soy protein isolate (contains 2 g leucine) was consumed daily by the other intervention group.
Active Comparator: Whey protein group
19 g whey protein isolate (contains 2 g leucine) was consumed daily by one intervention group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lean Body Mass Change
Time Frame: Post-12 week intervention
assessed using dual energy x-ray absorptiometry (DEXA) scan for changes in lean body mass (kg)
Post-12 week intervention
Muscle Tissue Thickness Change
Time Frame: Post-12 week intervention
assessed using changes in muscle thickness assessed by ultrasound (cm)
Post-12 week intervention
Leg Girth Changes
Time Frame: Post-12 week intervention
assessed using circumference measurements (cm)
Post-12 week intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Peak Torque When Doing Leg Extensions
Time Frame: Post-12 week intervention
Assessed using an isokinetic dynamometer set at 60 degrees of motion per second (d/s)
Post-12 week intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Heidi Lynch, PhD, Point Loma Nazarene University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2016

Primary Completion (Actual)

April 30, 2017

Study Completion (Actual)

April 30, 2017

Study Registration Dates

First Submitted

February 25, 2019

First Submitted That Met QC Criteria

March 6, 2019

First Posted (Actual)

March 11, 2019

Study Record Updates

Last Update Posted (Actual)

February 27, 2020

Last Update Submitted That Met QC Criteria

February 25, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 01435225

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skeletal Muscle Growth

Clinical Trials on Soy protein supplement

Subscribe